Genmab | GEN - Ebitda

Hisse Senedi Fiyatı
1,758.50
Günlük Değişim
-11.00 -0.62%
Aylık
-1.68%
Yıllık
36.32%
Q2 Tahmin
1,613.20




Ebitda Değişiklik Tarih
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Almirall EUR 114.07M 60.37M 2025-12
Amarin USD 12.54M 28.57M 2025-06
Amgen USD 5.14B 775M 2025-12
argenx SE USD 404.12M 17.08M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 1.97B 457M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Demant DKK 2.76B 165M 2025-12
Exelixis USD 242.86M 6.08M 2025-12
Fresenius Medical Care EUR 824M 250M 2026-03
Galapagos EUR 560.5M 558.08M 2025-12
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GN Store Nord DKK 491M 136M 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Insmed USD -314.19M 31.48M 2025-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 5.3B 530M 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12